EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vascularized and Perfusable Human Heart‐on‐a‐Chip Model Recapitulates Aspects of Myocardial Ischemia and Enables Analysis of Nanomedicine Delivery

Junyoung Kim iD, Xuening Zhang, Richard Wang, Adrian Najer, Qiao You Lau, Ana Cammack-Najera, Jang Ah Kim, Yoo Kyung Kang, Ruoxiao Xie, Hyemin Kim, Kai Xie, Hyeonji Lim und 3 weitere

Advanced Materials · 2025-10 · 37 (41)

DOI: 10.1002/adma.202418909 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 26.07.2025. Verfasst von Junyoung Kim und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Materials, Department of Bioengineering and Institute of Biomedical Engineering, Imperial College London, Prince Consort Road, London, …. Hauptthemen laut MEDLINE: Myocardial Ischemia, Nanomedicine, Lab-On-A-Chip Devices. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Engineering and Physical Sciences Research Council, British Heart Foundation, Korea Health Industry Development Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular diseases (CVDs) are the leading cause of death worldwide. However, the pathophysiological mechanisms of CVDs are not yet fully understood, and animal models do not accurately replicate human heart function. Heart‐on‐a‐chip technologies with increasing complexity are being developed to mimic aspects of native human cardiac physiology for mechanistic studies and as screening platforms for drugs and nanomedicines. Here, a 3D human myocardial ischemia‐on‐a‐chip platform incorporating perfusable vasculature in direct contact with myocardial regions is designed. Infusing a vasoconstrictor cocktail, including angiotensin II and phenylephrine, into this heart‐on‐a‐chip model leads to increased arrhythmias in cardiomyocyte pacing, fibroblast activation, and damage to blood vessels, all of which are hallmarks of ischemic heart injury. To verify the potential of this platform for drug and nanocarrier screening, a proof‐of‐concept study is conducted with cardiac homing peptide‐conjugated liposomes containing Alamandine. This nanomedicine formulation enhances targeting to the ischemia model, alleviates myocardial ischemia‐related characteristics, and improves cardiomyocyte beating. This confirms that the vascularized chip model of human myocardial ischemia provides both functional and mechanistic insights into myocardial tissue pathophysiology and can contribute to the development of cardiac remodeling medicines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial IschemiaNanomedicineLab-On-A-Chip DevicesHumansMyocytes, CardiacLiposomes

Stichwörter der Autor:innen

heart‐remodelingmyocardial ischemiananomedicinesvascularized heart‐on‐a‐chip

Substanzen

Liposomes

Autor:innen und Institutionen

  • Department of Materials, Department of Bioengineering and Institute of Biomedical Engineering, Imperial College London, Prince Consort Road, London, SW7 2AZ, UK.
  • Department of Physiology, Anatomy and Genetics, Department of Engineering Science, Kavli Institute for Nanoscience Discovery, University of Oxford, South Parks Road, Oxford, OX1 3QU, UK.
  • Department of Biomedical Engineering, Ulsan National Institute of Science and Technology (UNIST), Ulsan, 44919, Republic of Korea.
  • Graduate School of Health Science and Technology, Ulsan National Institute of Science and Technology (UNIST), Ulsan, 44919, Republic of Korea.
  • Center for Genomic Integrity, Institute for Basic Science, Ulsan, 44919, Republic of Korea.

ORCID-Profile: Junyoung Kim, Molly M Stevens

Förderung

  • Engineering and Physical Sciences Research Council
  • British Heart Foundation
  • Korea Health Industry Development Institute
  • National Research Foundation of Korea
  • Rosetrees Trust
  • Ministry of Science and ICT
  • Department of Science, Innovation and Technology and the Royal Academy of Engineering
  • Wellcome Trust

Zitieren

APA

Kim, J., Zhang, X., Wang, R., Najer, A., Lau, Q. Y., Cammack-Najera, A., Kim, J. A., Kang, Y. K., Xie, R., Kim, H., Xie, K., Lim, H., Park, T. E., Joo, J., & Stevens, M. M. (2025). Vascularized and Perfusable Human Heart‐on‐a‐Chip Model Recapitulates Aspects of Myocardial Ischemia and Enables Analysis of Nanomedicine Delivery. Advanced Materials, 37(41). https://doi.org/10.1002/adma.202418909

Vancouver

Kim J, Zhang X, Wang R, Najer A, Lau QY, Cammack-Najera A, et al. Vascularized and Perfusable Human Heart‐on‐a‐Chip Model Recapitulates Aspects of Myocardial Ischemia and Enables Analysis of Nanomedicine Delivery. Advanced Materials. 2025;37(41). doi:10.1002/adma.202418909

BibTeX
@article{Kim2025,
  author = {Kim, Junyoung and Zhang, Xuening and Wang, Richard and Najer, Adrian and Lau, Qiao You and Cammack-Najera, Ana and Kim, Jang Ah and Kang, Yoo Kyung and Xie, Ruoxiao and Kim, Hyemin and Xie, Kai and Lim, Hyeonji and Park, Tae-Eun and Joo, Jinmyoung and Stevens, Molly M},
  title = {Vascularized and Perfusable Human Heart‐on‐a‐Chip Model Recapitulates Aspects of Myocardial Ischemia and Enables Analysis of Nanomedicine Delivery},
  journal = {Advanced Materials},
  year = {2025},
  volume = {37},
  number = {41},
  doi = {10.1002/adma.202418909}
}
Kostenlos starten →